NFKB1 and gastric cancer: Tumor cells with an inactivated NF-κB pathway are sensitive to 5-fluorouracil chemotherapy32, while a gastric cancer cell line with NF-κB pathway activation acquired 5-fluorouracil chemotherapy resistance33.